Forensic Analysis · Healthcare / Pharmaceuticals / Biotech · as of Aug 10, 2026

Ufp Technologies Inc (UFPT)

A forensic read on Ufp Technologies Inc built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

A · High-quality compounder

Forensic grade

Safe

Financial health

15.4

Distress distance

Clean

Earnings quality

Forensic signals

33.8

P / E (ttm)

16.1%

ROE

$2.5B

Market cap

19.5%

Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Ufp Technologies Inc earns an A (High-quality compounder) forensic quality grade, and its balance-sheet distress test reads 15.4, placing it in the Safe zone. 3 forensic signals were flagged in its latest SEC filings, led by shareholder returns.

What the filings flag

FCF ($3M)

FY2015

Shareholder returns. Returned $587,000 to shareholders (buybacks + dividends) in FY2015, but free cash flow was ($3M) after capex — there was no free cash flow to fund the payout from at all, though operating cash flow alone was $13M — 5% of that. The entire return is coming from debt or cash reserves, not cash the business itself generated — a harder case than returns merely running ahead of free cash flow, since here there was none to run ahead of.

13.4%

FY2025

Return on invested capital. Return on invested capital is 13.4% in the latest fiscal year and steady — a modest positive spread over its ~10% cost of capital — growth adds value, though not dramatically.

+0.6%/yr

FY2022–FY2025

Share count. Diluted share count changed +2% over the last 3 years to FY2025 (+0.6%/yr). Roughly flat — the count is neither shrinking nor growing meaningfully. Per-share value isn't being meaningfully helped or hurt by the count.

Key fundamentals

Latest Revenue$602.8M

Revenue Growth YoY+19.5%

Revenue CAGR (3yr)+19.4%

Net Margin11.3%

Return on Equity16.1%

Debt / Equity0.32x

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Ufp Technologies Inc's actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Aug 10, 2026. Forensic signals flag probability, not certainty.